Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Single-dose 7.2mg semaglutide (Wegovy) pen approved to treat adult patients with obesity
Most prescribers recommend limiting or avoiding alcohol during semaglutide treatment
(2025) 314:na
Oral semaglutide tablets offer a needle-free option for people seeking GLP-1 therapy, with clinical trials demonstrating weight loss averaging 10-15% of body weight over 68 weeks in non-diabetic populations
References: UK Statutory Instrument 2004/1031 (as amended) Medicines for Human Use (Clinical Trials) Regulations
How It Works GLP-1 medications are typically administered through injections prescribed by a licensed medical practitioner
US$ 21.24
US$ 20.12
US$ 27.56
US$ 26.35
US$ 29.29
US$ 22.89
US$ 22.41
